Yoga for Persistent Sleep Disturbance in Cancer Survivors
OBJECTIVES:
Primary
- Determine the efficacy of Hatha yoga in improving sleep quality in cancer survivors
experiencing persistent sleep disturbance.
Secondary
- Determine the efficacy of yoga in improving fatigue and quality of life (QOL) of cancer
survivors.
- Determine if the positive effects of yoga on sleep are related to concurrent changes in
fatigue and QOL.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
gender and sleep disturbance rating reported on the eligibility assessment questionnaire (≤
5 vs > 5). Patients are randomized to 1 of 2 arms.
- Arm I: Patients receive standard care for 6 weeks. Patients may switch to the yoga
intervention immediately after study completion.
- Arm II:Patients receive standard care for 2 weeks, followed by two 75-minute sessions
of Hatha yoga per week for 4 weeks.
All patients complete Pittsburgh Sleep Quality Inventory, Insomnia Severity Index,
Functional Assessment of Chronic Illness Therapy-Fatigue, Sleep Medication and Complementary
and Alternative Medicine Usage, Symptom Inventory, Multidimensional Fatigue Symptom
Inventory, Profile of Mood States, and Aerobic Center Longitudinal Study Physical Activity
questionnaires at baseline and at study completion. Patients also wear an actigraph (a
device worn on the wrist to measure activity level) for 1 week before and for 1 week after
completion of study intervention. Patients also complete daily diaries for the duration of
the study.
PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.
Interventional
Allocation: Randomized, Primary Purpose: Supportive Care
Efficacy of Hatha yoga in improving sleep quality as measured by Pittsburgh Sleep Quality Inventory and Insomnia Severity Index
No
Karen M. Mustian, PhD
Principal Investigator
University of Rochester
United States: Federal Government
CDR0000515123
NCT00397930
October 2006
April 2010
Name | Location |
---|---|
CCOP - Wichita | Wichita, Kansas 67214-3882 |
CCOP - Kansas City | Kansas City, Missouri 64131 |
CCOP - Southeast Cancer Control Consortium | Winston-Salem, North Carolina 27104-4241 |
CCOP - Kalamazoo | Kalamazoo, Michigan 49007-3731 |
CCOP - Central Illinois | Springfield, Illinois 62526 |
CCOP - Columbus | Columbus, Ohio 43206 |
CCOP - Greenville | Greenville, South Carolina 29615 |
CCOP - Grand Rapids | Grand Rapids, Michigan 49503 |
CCOP - Columbia River Oncology Program | Portland, Oregon 97225 |
CCOP - Northwest | Tacoma, Washington 98405-0986 |
CCOP - Hematology-Oncology Associates of Central New York | East Syracuse, New York 13057 |